← Eichor
Condition: Dry Eye Syndromes Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Dry Eye Syndromes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Sy
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT05927688Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
Phase N/A · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06771427A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RE
Phase 2 · 6 location(s) · Lubris Bio Pty Ltd · NCT07118241The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function
Phase 4 · 1 location(s) · Southern California College of Optometry at Marshall B. Ketc · NCT06655441Ultra-High Frequency Ultrasonography in Sjögren's Syndrome
NA · 1 location(s) · University of Pisa · NCT06338735Difference of Tear Ferning Between Women with and Without Menopausal.
NA · 1 location(s) · Chung Shan Medical University · NCT06848829Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cata
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT06886373Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune D
Phase 4 · 1 location(s) · Toyos Clinic · NCT06964269Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Phase 2 · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT07281456Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Peking University Third Hospital · NCT06828042Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
Phase N/A · 1 location(s) · Attikon Hospital · NCT07605572Study of Proteomic Factors in Patients With Severe Dry Eye Syndrome Treated With Autologous Serum Eye Drops.
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT07632534Belimumab After Rituximab in Resistant Primary Juvenile SS
Phase 4 · 1 location(s) · Peking Union Medical College Hospital · NCT06410833Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Phase N/A · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04198740Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Fo
Phase 4 · 1 location(s) · Vance Thompson Vision · NCT07155070PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes
NA · 1 location(s) · Cairo University · NCT07366944Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Phase 3 · 28 location(s) · Vor Biopharma · NCT07404865A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Phase 1 · 19 location(s) · GlaxoSmithKline · NCT07371468Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06428188The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06830551Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye
Phase 1 · 1 location(s) · Iran University of Medical Sciences · NCT06543667The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
Phase 4 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04981145Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT06392711Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye
Phase 4 · 4 location(s) · Universiti Sains Malaysia · NCT07396441The Pathogenesis and Natural History of Sjogren's Disease
Phase N/A · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT01425892A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Phase 3 · 174 location(s) · Amgen · NCT06747949Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lu
Phase 4 · 1 location(s) · Andover Research Eye Institute · NCT07676084A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
Phase 3 · 1 location(s) · Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · NCT06766357Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Phase N/A · 1 location(s) · Duke University · NCT03276923An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
NA · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT06379646
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.